Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin

Allan D. Kirk, Roslyn B. Mannon, David E. Kleiner, John S. Swanson, Robert L. Kampen, Linda K. Cendales, Eric A. Elster, Terri Wakefield, Christine Chamberlain, Steven C. Hoffmann, Douglas A. Hale